Related Experiment Video
Updated: Jun 8, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetic Cardiomyopathy: What Clinicians Should Know
Hannah Smati1, Yusuf Kamran Qadeer2, Mario Rodriguez3
1Department of Medicine, Baylor College of Medicine, Houston, Tex.
Insights
Diabetic cardiomyopathy, a heart condition in diabetes patients, is increasingly recognized. Current diagnosis and treatment strategies for this heart failure complication remain challenging, highlighting an unmet clinical need.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetes is linked to atherosclerotic cardiovascular disease.
- Heart failure is a growing concern in diabetic patients, often presenting as the first cardiovascular complication.
- Diabetic cardiomyopathy is structural heart disease in diabetes, potentially causing heart failure independent of other risk factors.
Purpose of the Study:
- To review the metabolic and structural changes in diabetic cardiomyopathy.
- To evaluate current diagnostic and staging tools for diabetic cardiomyopathy.
- To describe emerging preclinical therapeutic options for diabetic cardiomyopathy.
Main Methods:
- Literature review of epidemiological data.
- Analysis of metabolic and structural changes in diabetic cardiomyopathy.
- Appraisal of diagnostic and staging tools.
- Review of preclinical therapeutic data.
Main Results:
- Diabetic cardiomyopathy is a significant complication of diabetes.
- Diagnosis and treatment of diabetic cardiomyopathy are challenging.
- There is a lack of specific therapies for diabetic cardiomyopathy, representing an unmet clinical need.
Conclusions:
- Diabetic cardiomyopathy is a key cardiovascular complication of diabetes.
- Improved diagnostic and therapeutic strategies are needed.
- Further research into preclinical data may yield future treatments for diabetic cardiomyopathy.
Abstract:
Diabetes has classically been associated with atherosclerotic cardiovascular disease. However, heart failure is now increasingly recognized as a prevalent and often first cardiovascular complication among patients with diabetes. Investigation of this epidemiological relationship has led to recognition of diabetic cardiomyopathy, or structural heart disease that develops in patients with diabetes and may lead to progressive heart failure independently of coronary artery disease or conventional cardiovascular risk factors such as hypertension. Despite increased awareness, clinical management of this common cardiovascular complication remains challenging, with no consensus on its diagnosis or treatment. The lack of specific therapy has been recognized as an unmet clinical need. In this review, we summarize current understanding of the hallmark metabolic and structural changes of diabetic cardiomyopathy, appraise current tools for diagnosis and staging among patients, and describe the emerging but still preclinical data on therapeutic options.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Myocarditis II: Clinical features and Diagnostic Tests
Myocarditis IV: Nursing Management
Myocarditis I: Introduction
Diabetes: Symptoms, Diagnosis, and Complications
Myocarditis III: Medical Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...